https://www.selleckchem.com/pr....oducts/s-glutamic-ac
Time to referral in the FP group was double that of the ED group (45 days (IQR 12-111) vs. 22 (IQR 5-69)) with more advanced disease (65% vs. 50%). In the FP group, 29% of the patients saw their FP three times or more before being referred and 41% had an ED visit. Our findings may reflect the challenge of diagnosing lung cancer in primary care, missed opportunities for earlier diagnosis, and a lack of integration between primary and specialist care. Our findings may reflect the challenge of diagnosing lung cancer in primary care
Mi piace
Commento
Condividi
